U.S. veterans who opt for fee-for-service health systems like Medicare are less likely to receive guideline-concordant care than their counterparts in the Veterans Health Administration (VA), researchers reported in a JAMA Network Open original investigation this month.

Rep. Mia Love, R-Utah, held a news conference Aug. 13 to call for Congress to permanently repeal the medical device tax. The House passed a bill to repeal the tax back in July, but the Senate has yet to take action.

A report evaluating five years of radiology-related medical professional liability claims found 80 percent of all diagnosis-related claims stem from the misinterpretation of clinical tests. Additionally, 80 percent of missed diagnosis claims in radiology result in either permanent injury or death.

Illinois Gov. Bruce Rauner has signed the state’s breast density reporting legislation into law, making it the 36th state with such a bill in place.

The U.S. Preventive Services Task Force recommends that physicians and patients take part in shared decision-making about both the benefits and the harms associated with lung cancer screening with low-dose CT (LDCT). According to a new study published in JAMA Internal Medicine, however, the quality of shared decision making in today’s healthcare environment is quite low.

The American College of Radiology (ACR) Liver Imaging Reporting and Data System (LI-RADS) Steering Committee has developed a new version of CT/MRI LI-RADS that is now in line with similar guidelines published by the American Association for the Study of Liver Diseases (AASLD).

A partnership between the American College of Radiology (ACR) and Veterans Healthcare Administration has bolstered the quality of care U.S. vets see at medical facilities across the country, according to a report published in the Journal of the American College of Radiology this month—and that’s only improving with the implementation of a mandatory three-year accreditation cycle.

Mammography services at a Sunrise, Florida, radiology center have been halted by the FDA until staff have sent cautionary letters to patients whose mammogram results might have been faulty, NBC Miami reported this week.